RT Journal Article
SR Electronic
T1 Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 294
DO 10.1186/s40425-019-0745-3
VO 7
IS 1
A1 Bretz, Anne Catherine
A1 Parnitzke, Ulrike
A1 Kronthaler, Kerstin
A1 Dreker, Tobias
A1 Bartz, René
A1 Hermann, Frank
A1 Ammendola, Astrid
A1 Wulff, Tanja
A1 Hamm, Svetlana
YR 2019
UL http://jitc.bmj.com/content/7/1/294.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.